The ACC document, which was endorsed by the American Diabetes Association (ADA), outlined a variety of considerations for use of these agents in patients with ASCVD, including considerations that may warrant selection of either a GLP-1 RA or an SGLT-2 inhibitor for cardiovascular risk reduction ( Table 1 )
Mehan S, Bhalla S, Siddiqui EM, Sharma N, Shandilya A, Khan A (2022) Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration
They help individuals navigate a culture that equates thinness with attractiveness, competence, and even employability
The GLP-1 monitoring tools for home use guide covers everything from smart scales and body composition analyzers to blood glucose monitors and blood pressure cuffs
Wegovy (semaglutide) is registered for weight management in the USA